Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125947361 | 12594736 | 1 | I | 20160204 | 20160726 | 20160726 | PER | US-UNITED THERAPEUTICS-UNT-2016-001844 | UNITED THERAPEUTICS | 0.00 | F | Y | 65.76000 | KG | 20160726 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125947361 | 12594736 | 1 | PS | TYVASO | TREPROSTINIL | 1 | 18-108 MICROGRAMS, QID | U | U | 2100761 | 22387 | INHALATION GAS | QID | ||||||
125947361 | 12594736 | 2 | C | WARFARIN | WARFARIN | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125947361 | 12594736 | 1 | Pulmonary hypertension |
125947361 | 12594736 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125947361 | 12594736 | Dyspnoea exertional | |
125947361 | 12594736 | Oedema peripheral | |
125947361 | 12594736 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125947361 | 12594736 | 1 | 20140911 | 0 |